8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension

NCT00327587 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2279

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Valsartan + amlodipine
DRUG: Valsartan + HCTZ
DRUG: Amlodipine + HCTZ
DRUG: Valsartan + amlodipine + HCTZ

Sponsor

Novartis